Guidelines for State
Licensing of Wholesale Drug Distributors
Reinstatement with change of a previously approved collection
No
Regular
02/22/2022
Requested
Previously Approved
36 Months From Approved
15,592
0
28,036
0
0
0
This information collection supports
implementation of sections 583 and 584 of the Federal Food, Drug,
and Cosmetic Act, as amended by the Drug Supply Chain Security Act
(DSCSA), requiring that FDA establish national standards for the
licensure of wholesale drug distributors and third-party logistic
providers. The regulations are intended to ensure that the supply
chain remains secure and that those prescription drugs subject to
the DSCSA that are moving through the supply chain are properly
stored, handled, and transported. These measures are intended to
help protect American consumers from drugs that may be counterfeit,
stolen, contaminated, or otherwise harmful.
We are revising regulations in
21 CFR part 205 and are revising the corresponding, inactive
information collection 0910-0251 to implement these
provisions.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.